Abstract
Parkinson’s disease (PD) is a common neurodegenerative disease which is characterized by a progressive degeneration of dopaminergic neurons in the midbrain. A most reliable mechanism causing the apoptosis in dopaminergic structures of the brain during aging and Parkinson’s disease is the activation of oxidative stress. Until now, effective means for the prevention of dopaminergic neurons degeneration and for the retention of damaged neurons functioning is still lacking. A promising way to slacken the pace of degenerative processes during aging and PD could be the adaptation to intermittent hypoxia. Such adaptation strengthens dopamine (DA) synthesis and release at peripheral chemoreceptors in carotid bodies and activates tyrosine hydroxylase – a rate-limiting enzyme for catecholamine synthesis. In this chapter, we examined three groups of rats: adult, old, and old rats with experimental DA deficiency. It was revealed that there was an asymmetry of dopamine distribution between the right and left striatum of adult rats. Prevalent quantity of dopamine was concentrated in right hemisphere. During aging DA, production decreased in the examined structures mainly in right hemisphere of the striatum, so its distribution asymmetry diminished. In PD animals, this decrease was much more expressed and led to practically total abolishment of quantitative difference between right and left hemispheres. Two-week course of intermittent hypoxia training (IHT, five cycles of 15-min exposures to 12% O2 followed by 15-min room air breathing per day) increased dopamine synthesis in old and experimental PD animals, especially in the right striatum, restored partially the asymmetry of DA distribution between brain hemispheres. IHT also decreased the intensity of lipid peroxidation. Increased plasma antioxidant activity positively correlated with increased DA concentration in the striatum. Therefore, IHT could serve as a good perspective means for the deceleration of aging and prevention/treatment of Parkinson’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 6-OHDA:
-
6-hydroxydopamine
- CAT:
-
Catalase
- CB:
-
Carotid bodies
- DA:
-
Dopamine
- EDAD:
-
Experimental DA deficiency
- GFAP:
-
Glial fibrillary acid protein
- HIF:
-
Hypoxia inducible factor
- IHT:
-
Intermittent hypoxia training
- MAO:
-
Monoamine oxidase
- MDA:
-
Malondialdehyde
- PD:
-
Parkinson’s disease
- ROS:
-
Reactive oxygen species
- SN:
-
Substantia nigra
- SOD:
-
Superoxide dismutase
- TH:
-
Tyrosine hydroxylase
References
Wei YH, Ma YS, Lee HC, et al. Mitochondrial theory of aging matures-roles of mtDNA mutation and oxidative stress in human aging. Zhonghua Yi Xue Za Zhi (Taipei). 2001;64:259–70.
Lee HC, Wei YH. Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med. 2007;232:592–606.
Orr WC, Sohal RS. Effects of Cu, Zn superoxide dismutase overexpression on life span and resistance to oxidative stress in transgenic drosophila melanogaster. Arch Biochem Biophys. 1993;301:34–40.
Kish SJ, Shannak K, Rajput A, et al. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson’s disease. J Neurochem. 1992;58:642–8.
Foster ER, Black KJ, Antenor-Dorsey JA, et al. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain Cogn. 2008;67:1–10.
Hershey T, Wu J, Weaver PM. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol. 2008;210:402–8.
Chuyan EN. Changes in motor asymmetry of low-intensive high-frequency electromagnetic radiation in normal conditions and under stress. Neurophysiology. 2005;37:164–8 [In Russian].
Carlson JN, Stewens KD. Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdale. Alcohol Clin Exp Res. 2006;30:1678–92.
Tomer R, Goldshtein RZ, Wang GJ, et al. Incentive motivation is associated with striatal dopamine asymmetry. Biol Psychol. 2008;77:98–101.
Belikova MV, Kolesnikova EE. Changes in rat striatum dopamine content under aging and dopamine insufficiency. Probl Aging Longevity. 2006;15:187–91 [In Russian].
Budilin S, Midzianovskaia IS, Shchegolevskii NV, et al. Asymmetry in the dopamine content in the nucleus accumbens and the motor preference in rats. Zh Vyssh Nerv Deiat Im I P Pavlova. 2007;57:598–603 [In Russian].
Tomer R, Aharon-Peretz J, Tsitrinbaum Z. Dopamine asymmetry interacts with medication to affect cognition in Parkinson’s disease. Neuropsychologia. 2007;45:357–67.
Vernaleken I, Weibrich C, Siessmeier T, et al. Asymmetry in dopamine D (2/3) receptors of caudate nucleus is lost with age. Neuroimage. 2007;34:870–8.
Bee D, Pallot DJ. Acute hypoxic ventilation, carotid body cell division and dopamine content during early hypoxia in rats. J Appl Physiol. 1995;79:1504–11.
Nurse CA, Jackson A, Makintaire F, et al. Adaptation of O2 chemoreceptors to hypoxia in vitro. In: Women at altitude. Burlingron: Queen City Printers Inc.; 1997. p. 147–53.
Vrecko K, Storga D, Bikmayer JG, et al. NADH stimulates endogenous dopamine biosynthesis by enhancing the recycling of tetrahydrobiopterin in rat phaeochromocytoma cells. Biochem Biophys Acta. 1997;1361:59–65.
Serebrovskaya TV. Intermittent hypoxia research in the former Soviet Union and the commonwealth of the independent states (CIS): history and review of the concept and selective application. High Alt Med Biol. 2002;3:205–21.
Bove J, Prou D, Perier C, et al. Toxin-induced models of Parkinson’s disease. NeuroRx. 2005;2:484–94.
Oleshko NN. Morphofunctional study of interaction of glutamate-, choline- and dopamine-ergic systems in neostriatum. Ross Fiziol Zh Im I M Sechenova. 1997;1–2:96–101 [In Russian].
Jacobowith PM, Richardson JS. Method for the rapid determination of norepinephrine, dopamine, serotonin in the same brain region. Pharmacol Biochem Behav. 1979;8:515–9.
Stal’naya ID, Garishvili TG. Method malondialdehyde evaluation with help of tiobarbituric acid. In: Orekhovich VN, editor. Modern methods in biochemistry. Moscow: Medicine; 1977. p. 66–7 [In Russian].
Chevari S, Chaba I, Sekei Y. The role of super oxide dismutase in oxidative processes in the cella and the method of its estimation in biological materials. Lab Delo. 1985;11:678–81. [In Russian].
Korolyuk MA, Ivanova AI, Majorova IT, et al. Method of catalase activity examination. Lab Delo. 1988;1:16–9 [In Russian].
Calne DB, Reppard RF. Aging of nigrostriatal pathway in human. Can J Neurol Sci. 1987;14:424–7.
Hornykiewicz O. Neurochimical patology and the ethiology of Parkinson’s disease: basic facts and hipotetical possibilities. Mt Sinai J Med. 1988;5:11–20.
Betarbet R, Sherer TB, Greenmyre JT. Animal models of Parkinson’s disease. Bioessays. 2002;24:308–18.
Kryzhanovski GN. Determinant structures in nervous system pathology. In: Generator mechanisms of neuropathological syndromes. Moscow; 1980. p. 360 [In Russian].
Kryzhanovski GN. General pathology of nervous system. Moscow; 1997, p. 352. [In Russian].
Chen J, Dinger B, Fidone SJ. Second messenger regulation of tyrosine hydroxilase gene expression in rat carotid body. Biol Signals. 1995;4:277–85.
Millhorn DE, Conforti L, Beitner-Johnson D, et al. Regulation of ionic conductances and gene expression by hypoxia in an oxygen sensitive cell line. Adv Exp Med Biol. 1996;410:135–42.
Raymond R, Millhorn DE. Regulation of tyrosine hydroxylase gene expression during hypoxia: role of Ca2+ and PKC. Kidney Int. 1997;51:536–41.
Lam SY, Tipoe GL, Long EC, et al. Differential expressions and roles of hypoxia-inducible factor-1alpha, -2alpha and -3alpha in the rat carotid body during chronic and intermittent hypoxia. Histol Histopathol. 2008;23:271–80.
Haavik J, Toska K. Tyrosine hydroxilase and Parkinson’s disease. Mol Neurobiol. 1998;16:285–309.
Ponzio F, Brunello N, Algeri S. Catecholamine synthesis in brain of aging rat. J Neurochem. 1978;30:1617–20.
Tumer N, Larochelle JS. Tyrosine hydroxylase expression in rat adrenal medulla: influence of age and cold. Pharmacol Biochem Behav. 1995;51:775–80.
Lopez-Barneo J, Ortega-Saenz P, Pardal R, et al. Oxygen sensing in the carotid body. Ann N Y Acad Sci. 2009;1177:119–31.
Kolesnikova EE, Safronova OS, Serebrovskaya TV. Age-related peculiarities of breathing regulation and antioxidant enzymes under intermittent hypoxic training. J Physiol Pharmacol. 2003;54:20–4.
Rizvi SI, Maurya PK. Alterations in antioxidant enzymes during aging in humans. Mol Biotechnol. 2007;37:58–61.
Gomes P, Simão S, Silva E, et al. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev. 2009;2:138–45.
Carvalho C, Santos MS, Baldeiras I, et al. Chronic hypoxia potentiates age-related oxidative imbalance in brain vessels and synaptosomes. Curr Neurovasc Res. 2010;7:288–300.
Gautam N, Das S, Mahapatra SK, et al. Age associated oxidative damage in lymphocytes. Oxid Med Cell Longev. 2010;3:275–82.
Mann DMA, Yates PO. Possible role of neuromelanin in the pathogenesis of Parkinson’s disease. Mech Ageing Dev. 1983;21:193–203.
Chiueh CC, Krishna G, Tulsi P, et al. Intracranial microdialysis of salicylic acid to detect hydroxyl radical generation through dopamine autooxidation in the caudate nucleus: effect of MPP+. Free Radic Biol Med. 1992;13:581–3.
Boldyrev AA. Dual role of free radical oxygen forms in ischemic brain. Neirochimiya. 1995;12:3–13 [In Russian].
Dexter DT, Holley AE, Flitter WD, et al. Parkinson’s disease increased levels of hydroxyperoxides in the Parkinsonian substantia nigra: an HPLC and ESR study. Mov Disord. 1994;9:92–7.
Yoritaka A, Hattori N, Uchida K, et al. Immunohistochemucal detection of 4-hydroxynonenal protein adducts in Parkinson’s disease. Proc Natl Acad Sci USA. 1996;93:2696–701.
Serra JA, Domínguez RO, de Lustig ES, et al. Parkinson’s disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson’s, Alzheimer’s and vascular dementia patients. J Neural Transm. 2001;108:1135–48.
Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson disease. Neurology. 1996;47:S161–70.
Martilla RG, Lorentz H, Rinne UK. Oxygen toxicity, protecting enzymes in Parkinson’s disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus. J Neurol Sci. 1988;86:321–31.
Yoritaka A, Hattori N, Mori H, et al. An immunohostochemical study on manganese superoxide dismutase in Parkinson’s disease. J Neurol Sci. 1997;148:181–6.
Smith TS, Bennet Jr JP. Mitochondrial toxins in models of neurodegenerative diseases. I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microialysis infusion of methylpyridinum or azide ions. Brain Res. 1997;765:183–8.
Yu YP, Ju WP, Li ZG, et al. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat. Brain Res. 2010;1336:58–65.
Gardner HW. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic Biol Med. 1989;7:65–86.
Piretti MV, Pagliuca G. Systematic isolation and identification of membrane lipid oxidation products. Free Radic Biol Med. 1989;7:219–21.
Davies KJA. Proteolytic systems as secondary antioxidant defenses. In: Chow CK, editor. Cellular antioxidant defense mechanisms. Boca Raton: CRC; 1988. p. 25–67.
Lindgren P, von Campenhausen S, Spottke E, et al. Cost of Parkinson’s disease in Europe. Eur J Neurol. 2005;12:68–73.
Koutsilieri E, Scheller S, Grunblatt E, et al. Free radicals in Parkinson’s disease. J Neurol. 2002;2:II1–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag London
About this chapter
Cite this chapter
Belikova, M.V., Kolesnikova, E.E., Serebrovskaya, T.V. (2012). Intermittent Hypoxia and Experimental Parkinson’s Disease. In: Xi, L., Serebrovskaya, T. (eds) Intermittent Hypoxia and Human Diseases. Springer, London. https://doi.org/10.1007/978-1-4471-2906-6_12
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2906-6_12
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2905-9
Online ISBN: 978-1-4471-2906-6
eBook Packages: MedicineMedicine (R0)